Tower Research Capital LLC (TRC) - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$35,000
+66.7%
656
+139.4%
0.01%
+150.0%
Q2 2015$21,000
+10.5%
274
-18.7%
0.00%0.0%
Q1 2015$19,0000.0%337
-41.8%
0.00%0.0%
Q4 2014$19,000
+46.2%
579
-27.6%
0.00%0.0%
Q4 2013$13,000
-74.5%
800
-83.4%
0.00%
-60.0%
Q3 2013$51,000
+218.8%
4,830
+72.1%
0.01%
+400.0%
Q2 2013$16,0002,8060.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$125,702,00041.75%
VHCP Management, LLC 1,178,474$138,718,00035.56%
Palo Alto Investors LP 2,579,154$303,592,00014.60%
Baker Brothers Advisors 4,135,412$486,779,0004.50%
APIS CAPITAL ADVISORS, LLC 23,000$2,708,0003.75%
EMORY UNIVERSITY 11,096$1,306,0003.64%
Atika Capital Management LLC 61,000$7,180,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 488,912$57,550,0002.78%
Segantii Capital Management Ltd 100,000$11,134,0002.55%
NEXT CENTURY GROWTH INVESTORS LLC 428,835$50,478,0002.10%
View complete list of ANACOR PHARMACEUTICALS INC shareholders